Your session is about to expire
← Back to Search
Other
Lasers for Sebaceous Hyperplasia
Phase 2
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-12 weeks
Awards & highlights
Study Summary
This trial is comparing three different treatments for sebaceous hyperplasia to see which is the most effective.
Who is the study for?
This trial is for adults over 18 in good health living in the Chicago area, seeking cosmetic treatment for sebaceous hyperplasia. They must understand and sign a consent form. Excluded are those with poor wound healing, recent sun exposure affecting skin pigment, pregnant or nursing individuals, and anyone unable to communicate or cooperate due to language barriers or mental impairment.Check my eligibility
What is being tested?
The study compares three treatments for sebaceous hyperplasia: Pulsed Dye Laser (PDL) plus Nd:YAG Laser; Erbium:YAG Laser; and Electrodessication & Curettage (ED&C). Each participant's lesions will be randomly assigned one of these treatments. Lesions get treated twice within 2-6 weeks and results are checked after 4-12 weeks.See study design
What are the potential side effects?
Potential side effects from the laser treatments may include redness, swelling, bruising, pain at the treatment site, changes in skin coloration, blistering and scarring. ED&C might cause similar reactions along with potential bleeding or infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in sebaceous hyperplasia lesion count
Change in size of sebaceous hyperplasia
Trial Design
3Treatment groups
Active Control
Group I: ED&C treatmentActive Control1 Intervention
Solitary lesions will be randomized to a group, thus, a patient may receive all three treatments, each on different lesions. Patients will undergo two total treatment sessions at 2-6 week intervals.
Group II: Erbium:YAG LaserActive Control1 Intervention
Solitary lesions will be randomized to a group, thus, a patient may receive all three treatments, each on different lesions. Patients will undergo two total treatment sessions at 2-6 week intervals.
Group III: PDL plus Nd:YAGActive Control2 Interventions
Solitary lesions will be randomized to a group, thus, a patient may receive all three treatments, each on different lesions. Patients will undergo two total treatment sessions at 2-6 week intervals.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,584 Previous Clinical Trials
917,747 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,562 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am getting cosmetic treatment for oily skin with bumps.I am 18 years old or older.I can communicate and cooperate with the study team.
Research Study Groups:
This trial has the following groups:- Group 1: ED&C treatment
- Group 2: Erbium:YAG Laser
- Group 3: PDL plus Nd:YAG
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What risks do patients face when subjected to Erbium:YAG Laser treatment?
"According to our team at Power, Erbium:YAG Laser holds a safety score of 2 on the scale from 1-3 since this is only Phase 2 trial and there are no clinical data that support its efficacy."
Answered by AI
Is this trial currently accepting new recruits?
"According to the information hosted on clinicaltrials.gov, this medical study is not presently recruiting patients. Initially posted in January of 2023, it was last updated in March of 2022 - at which time they had already closed recruitment efforts. Despite that fact, there are currently 132 other trials actively looking for volunteers."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger